Fetsch, V., Schwöbel, L., Göknar, E., Stell, A., Punta, M., Plenge, T., Klaus, T., Gupta, M., Andrieux, G., Shoumariyeh, K., Pfeiffer, S., Corrales, E., Schlenke, L., Baniadam, H., Brandl, S., Andreis, M., Remen, M., Hartmann, A., Grueter, K., Zwick, M., Koehler, N., Kuban, M., Metzger, E., Rummelt, C., Duyster, J., Boerries, M., Hofmann, M., Faerber, J., Braun, L., Zähringer, A., Lübbert, M., Toffalori, C., Vago, L., Heidel, F., Minguet, S., Apostolova, P., Feuchtinger, T., Maas-Bauer, K., Blaeschke, F., Kuhn, M., Timmers, H. M., Wertheimer, T., Perner, F., Zeiser, R. (2025). Post allo-HCT menin-inhibition enhances graft-versus-leukemia effects by endogenous retrovirus induction in AML and T-cell activation. Blood. https://doi.org/10.1182/blood-2025-5862